Spring Creek Capital Corporation Announces Acquisition, Letter of Intent

MERRITT ISLAND, FL, Apr 29 (MARKET WIRE) --
Spring Creek Capital Corporation (OTCBB: SCRK), a Nevada corporation,
announced today that it has entered into a binding Letter of Intent with
BioCube, Inc. for the development and market launch of BioCube's
proprietary, infectious disease decontamination system. Spring Creek
Capital recently elected to be treated as a business development
corporation (BDC) under the Investment Company Act of 1940 and will focus
on portfolio investments in companies developing cutting edge solutions
for the healthcare market. Closing is subject to completion of due
diligence by Spring Creek Capital and is expected to be on or before May
15, 2009.

BioCube, Inc. a Nevada corporation, is collaborating with its Russian
research partners to complete the development and then commercialization
of an environmentally safe decontamination system, utilizing an
aerosol-based delivery method. This system has demonstrated effective
handling of microbial and fungal cells, spores, and viruses that are the
core of such infections as MRSA, Avian Flu, Swine Flu and common molds.

Hospitals struggle with the control of infectious diseases and continue to
look for efficacious, environmentally friendly and cost-effective means of
dealing with this pervasive problem. BioCube intends to focus on this
existing market need for decontamination of patient rooms, operating
theaters, medical equipment and furniture, which exists in over 5,000
hospitals and nearly 1 million beds in the U.S. healthcare system, as well
as the many other uses of a similar decontamination solution.

BioCube will focus on the following target markets:

-- Healthcare (hospital, nursing homes)
-- Travel (airplanes, cruise ships, mobile homes)
-- Mold remediation
-- Schools
-- Animal farming
-- Agriculture

BioCube believes that its decontamination technology holds significant
promise as a long-term solution to a global problem. BioCube's objective
is to help create an effective technology that will allow for rapid,
inexpensive and environmentally safe remediation of buildings that have
been contaminated by a biological agent, thus allowing a speedy return to
a state of normalcy.

This press release may contain forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. Investors
are cautioned that these forward-looking statements involve uncertainties
and risks that could cause actual performance and results of operations to
differ materially from those anticipated. These risks and uncertainties
include issues related to the ability to: obtain sufficient funding to
continue operations, maintain adequate cash flow, profitably exploit new
ventures, as well as other factors set forth in Spring Creek Capital's
most recently filed Form 10-K and Form 10-Q reports. The forward-looking
statements contained herein represent the Company's judgment as of the
date of this release and it cautions readers not to place undue reliance
on such statements. Spring Creek Capital assumes no obligation to update
the statements contained in this release.

Contact:
Kelly T. Hickel
Telephone: 321-452-9091
Email Contact

Copyright 2009, Market Wire, All rights reserved.

-0-